Stemtech Corporation announced the appointment of Dr. Lizette Leos, MD to Chief Scientific Officer.
President & COO, John W. Meyer said, “Dr. Leos has been with Stemtech since 2017 and has significantly contributed to the science, creation and development, including education of our stemceuticals – all-natural, plant-based, non-GMO nutritional supplements designed to support the body’s own regenerative processes. Promoting her to the role of Chief Scientific Officer recognizes both her longstanding impact and leadership in the development of new evidence-driven innovations.”
“It is an honor to step into the role of Chief Scientific Officer at a pivotal moment in Stemtech’s evolution. Stemtech has been a pioneer in demonstrating how all-natural, plant-based nutrition can activate and support the body’s own regenerative capacity without reliance on synthetic or chemical interventions. My vision is to further strengthen our scientific governance, expand evidence-based education globally, and ensure that innovation, regulatory responsibility, and integrity remain at the core of everything we do as we advance the future of longevity and cellular health,” Dr. Leos commented.
Dr. Leos is a medical doctor based in Guadalajara, Mexico, and has worked with Stemtech since 2017. She holds a Master’s Degree in Aesthetic and Anti-Aging Medicine from the Instituto Mexicano de Medicina Antienvejecimiento y Estética (IMMAE) (2023), postgraduate training in Molecular Nutrition and Smart Food Design from Tecnológico de Monterrey, Campus Guadalajara (2018), and earned her Medical Degree from Universidad Guadalajara Lamar, with her professional title issued by the Universidad de Guadalajara (2007).
With over 10 years of experience in regenerative medicine, nutrigenomics, cellular health, and aesthetic medicine, Dr. Leos has served on the Stemtech Life Sciences Advisory Board, where she has designed global educational programs, scientific symposiums, and evidence-based clinical and educational protocols.
Leave a Reply